Day One Biopharmaceuticals, Inc. (DAWN)
8.265
-0.38
(-4.34%)
USD |
NASDAQ |
Dec 09, 16:00
8.265
0.00 (0.00%)
After-Hours: 17:02
Day One Biopharmaceuticals Profit Margin (Quarterly): -49.57% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Mersana Therapeutics, Inc. | -68.53% |
| Iovance Biotherapeutics, Inc. | -135.3% |
| Lantheus Holdings, Inc. | 7.23% |
| iRhythm Technologies, Inc. | -2.70% |
| Perspective Therapeutics, Inc. | -12.43K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -30.98% |
| Return on Assets | -27.58% |
| Return on Invested Capital | -30.80% |
| Gross Profit Margin (Quarterly) | 88.74% |
| Operating Margin (Quarterly) | -60.94% |
| Return on Net Operating Assets | -288.6% |